Jiangsu Jibeier Pharmaceutical Co Ltd (688566) — Cash Flow Reinvestment Rate
Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a Cash Flow Reinvestment Rate of 2.24x as of September 2025, reinvesting CN¥24.80 Million (capex CN¥24.80 Million ) from operating cash flow of CN¥11.07 Million. Explore 688566 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Jibeier Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Jiangsu Jibeier Pharmaceutical Co Ltd across 10 annual periods. Also explore 688566 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Jiangsu Jibeier Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 688566 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥121.63 Million | CN¥248.30 Million | CN¥114.60 Million | ▼ -41.4% |
| 2024 | 0.84x | CN¥180.07 Million | CN¥215.29 Million | CN¥174.53 Million | ▼ -80.6% |
| 2023 | 4.31x | CN¥687.59 Million | CN¥159.50 Million | CN¥357.37 Million | ▲ +38.8% |
| 2022 | 3.11x | CN¥468.19 Million | CN¥150.72 Million | CN¥292.70 Million | ▲ +225.3% |
| 2021 | 0.96x | CN¥143.79 Million | CN¥150.56 Million | CN¥83.79 Million | ▲ +33.9% |
| 2020 | 0.71x | CN¥83.68 Million | CN¥117.36 Million | CN¥23.68 Million | ▼ -8.8% |
| 2019 | 0.78x | CN¥90.22 Million | CN¥115.45 Million | CN¥30.22 Million | ▲ +12.3% |
| 2018 | 0.70x | CN¥68.19 Million | CN¥97.97 Million | CN¥8.19 Million | ▲ +102.6% |
| 2017 | 0.34x | CN¥38.36 Million | CN¥111.66 Million | CN¥18.78 Million | ▼ -81.4% |
| 2016 | 1.85x | CN¥72.56 Million | CN¥39.29 Million | CN¥46.69 Million | — |